{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:44:06Z","timestamp":1785915846811,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["P20224ZHM9 PRIN-PNRR"],"award-info":[{"award-number":["P20224ZHM9 PRIN-PNRR"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2019-12370133"],"award-info":[{"award-number":["GR-2019-12370133"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.parkreldis.2026.108374","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:36:06Z","timestamp":1780760166000},"page":"108374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolomic signatures supporting clinical stratification of Parkinson disease and atypical parkinsonism"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-7379","authenticated-orcid":false,"given":"Jacopo","family":"Troisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Pellecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Picillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4975-4722","authenticated-orcid":false,"given":"Annamaria","family":"Landolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6988-8197","authenticated-orcid":false,"given":"Marianna","family":"Amboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2026.108374_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108374_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/mds.30007","article-title":"International Parkinson and movement disorder society viewpoint on biological frameworks of Parkinson's disease","author":"Kalia","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108374_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The movement disorder society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108374_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2026.108374_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2026.108374_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"For the movement disorder Society-endorsed PSP study group, clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria: MDS clinical diagnostic criteria for PSP","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108374_bib7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/mds.27619","article-title":"Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy","volume":"34","author":"Ali","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108374_bib8","series-title":"International Review of Neurobiology","first-page":"1","article-title":"How to approach a patient with parkinsonism \u2013 red flags for atypical parkinsonism","author":"Mulroy","year":"2019"},{"key":"10.1016\/j.parkreldis.2026.108374_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","article-title":"A clinicopathologic study of 100 cases of parkinson's disease","volume":"50","author":"Hughes","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108374_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108374_bib11","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/s41598-024-53355-y","article-title":"The significance of glial cell line-derived neurotrophic factor analysis in progressive supranuclear palsy","volume":"14","author":"Alster","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2026.108374_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","article-title":"Genetics of Parkinson's disease","volume":"30","author":"Lill","year":"2016","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.parkreldis.2026.108374_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223113","article-title":"Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy","volume":"14","author":"Mori","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2026.108374_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jns.2017.08.1647","article-title":"Plasma metabolomics reveals low levels of antioxidants in PSP","volume":"381","author":"Akio","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2026.108374_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2018.02.022","article-title":"Serum metabolomics study in a group of Parkinson's disease patients from northern India","volume":"480","author":"Nagesh Babu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.parkreldis.2026.108374_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11306-019-1554-x","article-title":"A metabolomic signature of treated and drug-na\u00efve patients with Parkinson's disease: a pilot study","volume":"15","author":"Troisi","year":"2019","journal-title":"Metabolomics"},{"key":"10.1016\/j.parkreldis.2026.108374_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1039\/B906712B","article-title":"Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy","volume":"40","author":"Dunn","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.parkreldis.2026.108374_bib18","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS\u2010UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108374_bib19","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.20255","article-title":"Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108374_bib20","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/brain\/awm032","article-title":"A clinical rating scale for progressive supranuclear palsy","volume":"130","author":"Golbe","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2026.108374_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mdc3.12921","article-title":"Levodopa equivalent dose conversion factors: an updated proposal including opicapone and safinamide","volume":"7","author":"Schade","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2026.108374_bib22","series-title":"ADASYN: Adaptive Synthetic Sampling Approach for Imbalanced Learning","first-page":"1322","author":"He","year":"2008"},{"key":"10.1016\/j.parkreldis.2026.108374_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/metabo15040214","article-title":"Double-weighted bayesian model combination for metabolomics data description and prediction","volume":"15","author":"Troisi","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.parkreldis.2026.108374_bib24","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/bioinformatics\/btq418","article-title":"MetPA: a web-based metabolomics tool for pathway analysis and visualization","volume":"26","author":"Xia","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.parkreldis.2026.108374_bib25","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207905","article-title":"Validation study of the MDS criteria for the diagnosis of multiple system atrophy in the Mayo Clinic Brain Bank","volume":"101","author":"Sekiya","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108374_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.parkreldis.2026.108374_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/biomedicines8090295","article-title":"The biomedical uses of inositols: a nutraceutical approach to metabolic dysfunction in aging and neurodegenerative diseases","volume":"8","author":"L\u00f3pez-Gambero","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.parkreldis.2026.108374_bib28","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3233\/JAD-170450","article-title":"Decreased N-Acetyl Aspartate\/myo-inositol ratio in the posterior cingulate cortex shown by magnetic resonance spectroscopy may be one of the risk markers of preclinical Alzheimer's disease: a 7-Year Follow-Up study","volume":"60","author":"Waragai","year":"2017","journal-title":"JAD"},{"key":"10.1016\/j.parkreldis.2026.108374_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101774","article-title":"Unbiased proteomic profiling reveals the IP3R modulator AHCYL1\/IRBIT as a novel interactor of microtubule-associated protein tau","volume":"298","author":"Wischhof","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.parkreldis.2026.108374_bib30","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3233\/JAD-210417","article-title":"Blockage of Fc gamma receptors alleviates neuronal and microglial toxicity induced by palmitic acid","volume":"82","author":"Phitthayaphong","year":"2021","journal-title":"JAD"},{"key":"10.1016\/j.parkreldis.2026.108374_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neures.2022.08.006","article-title":"DJ-1 inhibits glutathione degradation by downregulating CHAC1 expression in astrocytes","volume":"184","author":"Ge","year":"2022","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.parkreldis.2026.108374_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/febs.15340","article-title":"Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage\u2010gated calcium channels and NADPH oxidase","volume":"288","author":"Esteras","year":"2021","journal-title":"FEBS J."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:46:25Z","timestamp":1785912385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"alternative-id":["S1353802026002014"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108374","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic signatures supporting clinical stratification of Parkinson disease and atypical parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108374"}}